Completion of pharmacokinetics for the MAD portion of the RR-HNK phase 1 study

Ended Purchase Order Awarded Last action

Contract number
75N95023P00236
Awardee
Awarding agency
Obligated
$108,254

Award facts

Contract value 100% obligated
$108,254.16 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Madison, WI 53704, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · FY26 UDO initiative. Completion of pharmacokinetics for the MAD portion of the RR-HNK phase 1 study -$6,111
Exercise an Option P00001 $13,029
Original award $101,336

About this award

The National Institute on Drug Abuse issued a purchase order to Labcorp Early Development Laboratories Inc. valued at $108,254.16 on July 1, 2023, for completion of pharmacokinetics for the MAD portion of the RR-HNK Phase 1 study under the FY26 UDO initiative. Work is performed in Madison, Wisconsin. The order carries a firm fixed price structure and was not set-aside. Ultimate completion date was June 30, 2025.

Quick answers

Who was awarded contract 75N95023P00236?

75N95023P00236 was awarded to Labcorp Early Development Laboratories Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 1, 2023.

How much is contract 75N95023P00236 worth?

The government has obligated $108,254 on 75N95023P00236.

Was contract 75N95023P00236 competed?

The extent of competition for 75N95023P00236 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award